Maggi, Ricardo G. http://orcid.org/0000-0001-7428-0138
Calchi, Ana Cláudia http://orcid.org/0000-0002-4096-5937
Moore, Charlotte O. http://orcid.org/0000-0002-1173-6019
Kingston, Emily
Breitschwerdt, Edward B. http://orcid.org/0000-0002-3506-0279
Funding for this research was provided by:
Steven and Alexandra Cohen Foundation
Article History
Received: 9 April 2024
Accepted: 29 June 2024
First Online: 11 July 2024
Declarations
:
: Testing of individuals done as a component of an Institutional Review Board (IRB) approved study entitled: Detection of <i>Bartonella</i> Species in the Blood of People with Extensive Animal Contact (North Carolina State University Institutional Review Board, IRB#s 4925-03 and 164-08-05). Permission to test for other infectious agents was individually granted.
: Not applicable.
: In conjunction with Dr. S. Sontakke and North Carolina State University, E.B. Breitschwerdt holds US Patent No. 7,115,385 Media and Methods for Cultivation of Microorganisms, which was issued on October 3rd, 2006. He is a co-founder, shareholder and Chief Scientific Officer for Galaxy Diagnostics, a company that provides advanced diagnostic testing for the detection of <i>Bartonella</i> spp. infections. Dr. Ricardo Maggi is a co-founder and the Chief Technical Officer for Galaxy Diagnostics Inc. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.